Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya.

ABSTRACT:

Background

Annually, about 2.7 million snakebite envenomings occur globally. Alongside antivenom, patients usually require additional care to treat envenoming symptoms and antivenom side effects. Efforts are underway to improve snakebite care, but evidence from the ground to inform this is scarce. This study, therefore, investigated the availability, affordability, and stock-outs of antivenom and commodities for supportive snakebite care in health facilities across Kenya.

Methodology/principal findings

This study used an adaptation of the standardised World Health Organization (WHO)/Health Action International methodology. Data on commodity availability, prices and stock-outs were collected in July-August 2020 from public (n = 85), private (n = 36), and private not-for-profi

SUBMITTER: Ooms GI 

PROVIDER: S-EPMC8389522 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature